Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma

NCT04234022 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Zn-DDC
DRUG: Lanalidomide with Zn-DDC
DRUG: Pomalidomide with Zn-DDC

Sponsor

The Royal Wolverhampton Hospitals NHS Trust

Collaborators

[object Object]